Mounjaro vs Zepbound
Same active ingredient (tirzepatide) but different FDA approvals: Mounjaro for diabetes, Zepbound for weight management.
Side-by-Side Comparison
| Mounjaro | Zepbound | |
|---|---|---|
| Generic Name | Tirzepatide | Tirzepatide |
| Manufacturer | Eli Lilly | Eli Lilly |
| FDA Uses | Type 2 diabetes | Chronic weight management |
| Dosing | 2.5mg escalating to 15mg weekly injection | 2.5mg escalating to 15mg weekly injection |
| Monthly Cost | $1,023 | $1,060 |
| With Insurance | $25–$150 | $25–$550 |
| Common Side Effects | Nausea, Diarrhea, Decreased appetite, Vomiting, Constipation | Nausea, Diarrhea, Vomiting, Constipation, Injection site reactions |
Check what benefits you qualify for
Answer 9 questions. See every program you're eligible for. Free.
Frequently Asked Questions
Which is better, Mounjaro or Zepbound?
Same active ingredient (tirzepatide) but different FDA approvals: Mounjaro for diabetes, Zepbound for weight management. The best choice depends on your specific condition, insurance coverage, and how your body responds. Talk to your doctor about which is right for you.
Is Mounjaro cheaper than Zepbound?
Mounjaro costs $1,023/month while Zepbound costs $1,060/month without insurance. With insurance, copays may be similar depending on your plan's formulary.
Can I switch from Mounjaro to Zepbound?
Switching between these medications should only be done under your doctor's supervision. They may need to adjust dosing and monitor for side effects during the transition.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.